International Conference on Psychosocial Advances in Neuro Oncology - (ICPANO-27)


17th - 18th March, 2027 | Suez, Egypt

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

15th February, 2027

Paper Submission Deadline

20th February, 2027

Last Date Of Registration

2nd March, 2027

Date Of Conference

17th - 18th March, 2027

Downloads

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 10 SDG 10 — Reduced Inequalities
SDG 11 SDG 11 — Sustainable Cities and Communities
SDG 16 SDG 16 — Peace, Justice and Strong Institutions
SDG 17 SDG 17 — Partnerships for the Goals
Explore

All Session Tracks

Track 01
Innovations in Neuro Oncology Treatments

This track focuses on the latest advancements in treatment modalities for neuro oncology, including novel pharmacological approaches and surgical techniques. Emphasis will be placed on the integration of multidisciplinary strategies to enhance patient outcomes.

Track 02
Psychosocial Dimensions of Cancer Care

This session will explore the psychological and social challenges faced by patients with neuro cancers and their families. Discussions will include coping mechanisms, support systems, and the role of mental health professionals in oncology.

Track 03
Neuroimaging Techniques in Oncology

This track will cover cutting-edge neuroimaging technologies and their applications in diagnosing and monitoring brain and spinal cord tumors. Participants will discuss the implications of imaging findings on treatment planning and patient management.

Track 04
Ethics in Neuro Oncology Research

This session will address the ethical considerations surrounding clinical trials and research in neuro oncology. Topics will include informed consent, patient autonomy, and the ethical implications of emerging therapies.

Track 05
Genetic and Molecular Insights in CNS Malignancies

This track will delve into the genetic and molecular underpinnings of central nervous system malignancies. Presentations will highlight the role of genomics in personalized medicine and targeted therapies.

Track 06
Cognitive Disorders in Cancer Patients

This session will examine the impact of cancer and its treatments on cognitive function in patients. Discussions will focus on assessment tools, interventions, and the importance of cognitive rehabilitation.

Track 07
Clinical Trials in Neuro Oncology

This track will provide an overview of ongoing and completed clinical trials in neuro oncology, highlighting innovative therapies and trial design. Participants will discuss challenges and strategies for improving trial outcomes.

Track 08
Neuroinflammation and Cancer

This session will explore the relationship between neuroinflammation and cancer progression in the central nervous system. Research findings will be presented on how inflammatory processes can influence tumor behavior and treatment responses.

Track 09
Advances in Neurosurgery for Tumor Management

This track will focus on the latest surgical techniques and technologies in the management of brain and spinal cord tumors. Emphasis will be placed on minimally invasive approaches and their impact on patient recovery.

Track 10
Vascular Neurology and Cancer Interactions

This session will discuss the interplay between vascular neurology and cancer, including the effects of tumors on cerebrovascular health. Presentations will cover diagnostic challenges and therapeutic strategies.

Track 11
Historical Perspectives in Neurology and Oncology

This track will provide insights into the historical development of neurology and oncology as interrelated fields. Participants will explore key milestones and their relevance to contemporary practices in neuro oncology.